Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 466 AL 480

Is (123)I-MIBG cardiac scintigraphy a surrogate marker for Parkinson's disease?

Fukuyama H.

Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):1-2. doi: 10.1007/s00259-009-1215-9.

Validation of cardiac (123)I-MIBG scintigraphy in patients with Parkinson's disease who were diagnosed with dopamine PET

Ishibashi K, Saito Y, Murayama S, Kanemaru K, Oda K, Ishiwata K, Mizusawa H, Ishii K.

Eur J Nucl Med Mol Imaging. 2010 Jan;37(1):3-11. doi: 10.1007/s00259-009-1202-1.

Copper in diseases and treatments, and copper-based anticancer strategies

Tisato F, Marzano C, Porchia M, Pellei M, Santini C.

Med Res Rev. 2010 Jul;30(4):708-49. doi: 10.1002/med.20174.

[Gait and balance disorders in patients with atypical parkinsonian syndromes]

Welter ML, Westby GW, Chastan N.

Rev Neurol (Paris). 2010 Feb;166(2):188-95. doi: 10.1016/j.neurol.2009.05.016. Epub 2009 Aug 4.

The neural circuitry of executive functions in healthy subjects and Parkinson's disease

Leh SE, Petrides M, Strafella AP.

Neuropsychopharmacology. 2010 Jan;35(1):70-85. doi: 10.1038/npp.2009.88.

Neurotoxic cyanobacterial toxins

Aráoz R, Molgó J, Tandeau de Marsac N.

Toxicon. 2010 Oct;56(5):813-28. doi: 10.1016/j.toxicon.2009.07.036. Epub 2009 Aug 4.

Cholesterol involvement in the pathogenesis of neurodegenerative diseases

Liu JP, Tang Y, Zhou S, Toh BH, McLean C, Li H.

Mol Cell Neurosci. 2010 Jan;43(1):33-42. doi: 10.1016/j.mcn.2009.07.013. Epub 2009 Aug 4.

Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study

Colosimo C, Morgante L, Antonini A, Barone P, Avarello TP, Bottacchi E, Cannas A, Ceravolo MG, Ceravolo R, Cicarelli G, Gaglio RM, Giglia L, Iemolo F, Manfredi M, Meco G, Nicoletti A, Pederzoli M, Petrone A, Pisani A, Pontieri FE, Quatrale R, Ramat S, Scala R, Volpe G, Zappulla S, Bentivoglio AR, Stocchi F, Trianni G, Del Dotto P, Simoni L, Marconi R; PRIAMO STUDY GROUP.

J Neurol. 2010 Jan;257(1):5-14. doi: 10.1007/s00415-009-5255-7. Epub 2009 Aug 9.

Safety and tolerability of rivastigmine capsule with memantine in patients with probable Alzheimer's disease: a 26-week, open-label, prospective trial (Study ENA713B US32)

Olin JT, Bhatnagar V, Reyes P, Koumaras B, Meng X, Brannan S.

Int J Geriatr Psychiatry. 2010 Apr;25(4):419-26. doi: 10.1002/gps.2355.

The benefits of a standardized patient education program for patients with Parkinson's disease and their caregivers

A'Campo LE, Wekking EM, Spliethoff-Kamminga NG, Le Cessie S, Roos RA.

Parkinsonism Relat Disord. 2010 Feb;16(2):89-95. doi: 10.1016/j.parkreldis.2009.07.009. Epub 2009 Aug 11.

Subthalamic nucleus deep brain stimulator placement using high-field interventional magnetic resonance imaging and a skull-mounted aiming device: technique and application accuracy

Starr PA, Martin AJ, Ostrem JL, Talke P, Levesque N, Larson PS.

J Neurosurg. 2010 Mar;112(3):479-90. doi: 10.3171/2009.6.JNS081161.

Deep brain stimulation for Parkinson disease

Lozano AM.

J Neurosurg. 2010 Mar;112(3):477; discussion 477-8. doi: 10.3171/2009.6.JNS09894.

The effect of Parkinson's disease on the dynamics of on-line and proactive cognitive control during action selection

Wylie SA, Ridderinkhof KR, Bashore TR, van den Wildenberg WP.

J Cogn Neurosci. 2010 Sep;22(9):2058-73. doi: 10.1162/jocn.2009.21326.

Apathy in drug-naïve patients with incident Parkinson's disease: the Norwegian ParkWest study

Pedersen KF, Alves G, Brønnick K, Aarsland D, Tysnes OB, Larsen JP.

J Neurol. 2010 Feb;257(2):217-23. doi: 10.1007/s00415-009-5297-x. Epub 2009 Aug 25.

Immediate effects of thermal-tactile stimulation on timing of swallow in idiopathic Parkinson's disease

Regan J, Walshe M, Tobin WO.

Dysphagia. 2010 Sep;25(3):207-15. doi: 10.1007/s00455-009-9244-x. Epub 2009 Aug 26.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias